KEVZARA

Google image searchProduct monograph

Active ingredient

sarilumab, 200 MG/1.14 ML

DIN: 02460548

Dosage form(s): SOLUTION

Route(s) of administration: SUBCUTANEOUS

Description: 1.14 ML PREFILLED SYRINGES

Schedule: Prescription / Schedule D

Company: SANOFI-AVENTIS CANADA INC

Date: 08-FEB-2017

ATC:

• L04 — IMMUNOSUPPRESSANTS (ATC, ATC/DDD, )
• L04A — IMMUNOSUPPRESSANTS (ATC, ATC/DDD)
• L04AC — Interleukin inhibitors (ATC, ATC/DDD)
• L04AC14 — SARILUMAB (ATC/DDD)

External Links for Kevzara

Search on Google

• Kevzara side effects
• Kevzara dosage
• sarilumab side effects
• sarilumab dosage

Sanofi-Aventis Canada Inc

Go to Sanofi-Aventis website to see drug product details. Sometimes you can find kevzara photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.